Carlos Singer

university of miami

H指数:50

被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Factors affecting minority enrollment in Parkinson's disease genetic testing

PARKINSONISM & RELATED DISORDERS

IF3.4

2024-08-010

PRE

Parkinson's disease variant detection and disclosure: PD GENEration, a North American study

BRAIN

IF11.7

2024-07-303

OAAI

Cook, Lola; Verbrugge, Jennifer; Schwantes-An, Tae-Hwi; Schulze, Jeanine; Foroud, Tatiana; Hall, Anne; Marder, Karen S.; Mata, Ignacio F.; Mencacci, Niccolo E.; Nance, Martha A.; Schwarzschild, Michael A.; Simuni, Tanya; Bressman, Susan; Wills, Anne-Marie; Fernandez, Hubert H.; Litvan, Irene; Lyons, Kelly E.; Shill, Holly A.; Singer, Carlos; Tropea, Thomas F.; Arroyave, Nora Vanegas; Carbonell, Janfreisy; Vicioso, Rossy Cruz; Katus, Linn; Quinn, Joseph F.; Hodges, Priscila D.; Meng, Yan; Strom, Samuel P.; Blauwendraat, Cornelis; Lohmann, Katja; Casaceli, Cynthia; Rao, Shilpa C.; Galvelis, Kamalini Ghosh; Naito, Anna; Beck, James C.; Alcalay, Roy N.

Ulotaront, a Trace Amine-Associated Receptor 1/Serotonin 5-HT1A Agonist, in Patients With Parkinson Disease Psychosis: A Pilot Study

NEUROLOGY-CLINICAL PRACTICE

IF3.2

2023-08-0110

OAAI

OPTN: A Possible Genetic Cause of Both CBS and ALS

NEUROLOGY

IF8.5

2023-04-250

PRE

Amantadine Revisited: A Contender for Initial Treatment in Parkinson's Disease?

CNS DRUGS

IF7.4

2021-10-1416

PREAI

Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical Trial

加压素1a拮抗剂SRX246在易激惹亨廷顿舞蹈病患者中的安全性和耐受性-一项随机2期临床试验

JOURNAL OF CLINICAL MEDICINE

IF2.9

2020-11-1618

OAAI

Brownstein, Michael J.; Simon, Neal G.; Long, Jeffrey D.; Yankey, Jon; Maibach, Hilda T.; Cudkowicz, Merit; Coffey, Christopher; Conwit, Robin A.; Lungu, Codrin; Anderson, Karen E.; Hersch, Steven M.; Ecklund, Dixie J.; Damiano, Eve M.; Itzkowitz, Debra E.; Lu, Shifang; Chase, Marianne K.; Shefner, Jeremy M.; McGarry, Andrew; Thornell, Brenda; Gladden, Catherine; Costigan, Michele; O'Suilleabhain, Padraig; Marshall, Frederick J.; Chesire, Amy M.; Deritis, Paul; Adams, Jamie L.; Hedera, Peter; Lowen, Kelly; Rosas, H. Diana; Hiller, Amie L.; Quinn, Joseph; Keith, Kellie; Duker, Andrew P.; Gruenwald, Christina; Molloy, Angela; Jacob, Cara; Factor, Stewart; Sperin, Elaine; Bega, Danny; Brown, Zsazsa R.; Seeberger, Lauren C.; Sung, Victor W.; Benge, Melanie; Kostyk, Sandra K.; Daley, Allison M.; Perlman, Susan; Suski, Valerie; Conlon, Patricia; Barrett, Matthew J.; Lowenhaupt, Stephanie; Quigg, Mark; Perlmutter, Joel S.; Wright, Brenton A.; Most, Elaine; Schwartz, Guy J.; Lamb, Jessica; Chuang, Rosalind S.; Singer, Carlos; Marder, Karen; Moran, Joyce A.; Singleton, John R.; Zorn, Meghan; Wall, Paola V.; Dubinsky, Richard M.; Gray, Carolyn; Drazinic, Carolyn

The retina as a window to the basal ganglia: Systematic review of the potential link between retinopathy and hyperkinetic disorders in diabetes

PARKINSONISM & RELATED DISORDERS

IF3.4

2020-11-019

PREAI

Minority Enrollment in Parkinson's Disease Clinical Trials: Meta-Analysis and Systematic Review of Studies Evaluating Treatment of Neuropsychiatric Symptoms

帕金森氏病临床试验的少数民族入组: 评估神经精神症状治疗研究的荟萃分析和系统评价

JOURNAL OF PARKINSONS DISEASE

IF5

2020-10-2717

PRE

From Mucuna Pruriens to deep brain stimulation: A two-decade case history

PARKINSONISM & RELATED DISORDERS

IF3.4

2020-08-013

PREAI

Management of Urologic and Sexual Dysfunction in Parkinson Disease

帕金森病的泌尿系统和性功能障碍的管理

CLINICS IN GERIATRIC MEDICINE

IF3.9

2020-02-0111

PREAI

Parkinson Disease Preface

CLINICS IN GERIATRIC MEDICINE

IF3.9

2020-02-011

OAAI

Tandem gait abnormality in Parkinson disease: Prevalence and implication as a predictor of fall risk

PARKINSONISM & RELATED DISORDERS

IF3.4

2019-06-017

PREAI

Gender Disparities in Deep Brain Stimulation for Parkinson's Disease

NEUROMODULATION

IF3.5

2019-06-0140

PREAI

Revisiting eligibility for deep brain stimulation: Do preoperative mood symptoms predict outcomes in Parkinson's disease patients?

PARKINSONISM & RELATED DISORDERS

IF3.4

2019-06-016

PREAI

Teaching NeuroImages: Severe spasms resembling status dystonicus as an unusual presentation of stiff-person syndrome

NEUROLOGY

IF8.5

2019-02-120

OAAI

Relationship between the MDS-UPDRS and Quality of Life: A large multicenter study of 3206 patients

PARKINSONISM & RELATED DISORDERS

IF3.4

2018-07-0154

OAAI

Skorvanek, Matej; Martinez-Martin, Pablo; Kovacs, Norbert; Zezula, Ivan; Rodriguez-Violante, Mayela; Corvol, Jean-Christophe; Taba, Pille; Seppi, Klaus; Levin, Oleg; Schrag, Anette; Aviles-Olmos, Iciar; Alvarez-Sanchez, Mario; Arakaki, Tomoko; Aschermann, Zsuzsanna; Benchetrit, Eve; Benoit, Charline; Bergareche-Yarza, Alberto; Cervantes-Arriaga, Amin; Chade, Anabel; Cormier, Florence; Datieva, Veronika; Gallagher, David A.; Garretto, Nelida; Gdovinova, Zuzana; Gershanik, Oscar; Grofik, Milan; Han, Vladimir; Kadastik-Eerme, Liis; Kurtis, Monica M.; Mangone, Graziella; Martinez-Castrillo, Juan Carlos; Mendoza-Rodriguez, Amelia; Minar, Michal; Moore, Henry P.; Muldmaa, Mari; Mueller, Christoph; Pinter, Bernadette; Poewe, Werner; Rallmann, Karin; Reiter, Eva; Rodriguez-Blazquez, Carmen; Singer, Carlos; Valkovic, Peter; Goetz, Christopher G.; Stebbins, Glenn T.

Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson's Disease (vol 32, pg 387, 2018)

CNS DRUGS

IF7.4

2018-04-104

OAAI

Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson's Disease

CNS DRUGS

IF7.4

2018-03-1252

OAAI

Association of metabolic syndrome and change in Unified Parkinson's Disease Rating Scale scores

NEUROLOGY